Pharma investment in UK picks up after last year’s lull, trade group says
UK pharma investment jumps to £167.2M in H1 2026 — nearly double all of 2025 — as pricing reforms lure drugmakers back, ABPI says. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing:…
The UK government's move to pay more for medicines and foster a closer relationship with drugmakers appears to have led to an increase in the pharma industry's investment into the country, according to a
Source: Endpoints News